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ABSTRACT.  The synthesis of new capped silica mesoporous nanoparticles for on-command delivery 
applications is described. The gate-like functional hybrid systems consisted of nanoscopic MCM-41-
based materials functionalized on the pore outlets with different ‘saccharide’ derivatives and a dye 
contained in the mesopores. A series of hydrolyzed starch products as ‘saccharides’ were selected. The 
mesoporous silica nanoparticles S1, S2 and S3 containing the grafted starch derivatives Glucidex® 47, 
Gludicex® 39 and Glucidex® 29, were synthesized. Additionally, for comparative purposes solid S4, 
containing lactose was prepared. Delivery studies in pure water in the presence of pancreatin or β-D-
galactosidase  were carried out for S1-S3 and S4, respectively. S1, S2 and especially S3 showed very 
low release in the absence of enzyme, but displayed cargo delivery in the presence of the corresponding 
enzyme. Moreover, nanoparticles of S1 were used to study the controlled release of the dye in 
intracellular media. Cell viability assays using HeLa and LLC-PK1 cells indicated that S1 nanoparticles 
were devoid of unspecific cell toxicity. The Endocytosis process for S1 nanoparticle internalization in 
HeLa cells was confirmed and the anchored starch was degraded by the lysosomal enzymes. 
Furthermore, a new mesoporous silica nanoparticle functionalized with Glucidex® 47 and loaded with a 
cytotoxic, S1-DOX was developed. The cell viability with S1-DOX decreased due to the internalization 
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of the nanoparticle, enzyme-dependent opening of the “saccharide” molecular gate and the consequent 
release of the cytotoxic agent. As far as the authors know, this is the first example of enzyme-induced in 
cell delivery using capped silica mesoporous nanoparticles. 
KEYWORDS. Carbohydrates, enzyme, intracellular controlled release, mesoporous, and gate. 
BRIEFS.  Mesoporous silica nanoparticles functionalized with certain ‘saccharides’ were prepared, fully 
characterized and used for an enzyme-triggered controlled release of an entrapped guest in in vitro and 
in ex vivo assays.  
 
Controlled release of therapeutic drugs, peptides or nucleic acid fragments in a specific cell is a new 
and promising research field in biomedical sciences. Traditional delivery systems are in most cases 
based on polymers that usually release their cargo via diffusion-controlled processes or through 
degradation of the polymer container.1-7 In recent years, as an alternative to polymeric materials, silica 
mesoporous supports (SMPS) have been used as inorganic scaffolds for the storage and release of drugs 
and organic molecules.8-10 Silica mesoporous supports provide unique features such as stability, 
biocompatibility, large load capacity, and the possibility to include gate-like scaffoldings on the external 
surface for the design of nanodevices for on-command delivery applications.11-16 Most of the gated 
stimuli-responsive systems are based on bio-channels and bio-gates that utilize movable mechanisms 
triggered by specific stimuli. SMPS-based systems with control release properties have been reported.  
Such systems, containing different gate-like scaffoldings, are sensitive to changes in the media pH or 
redox conditions as well as to light as triggers for uncapping the pores.17-19 
The first gated SMPS was developed by Fujiwara et al.20,21 via reversible photodimerization of 
coumarin attached to the pore outlets that were sensitive to light. Since then, other photochemical gated 
systems based on cis-trans isomerization of azobenzene moieties,22-25 the association and light-operated 
dissociation of a α-cyclodextrin with azobenzene groups26-28 and the spiropyran-merocynine photo 
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switchable transformation29 have been reported. pH is also a widely used stimulus for the control of 
mass transport in mesoporous materials. The authors recently reported the first gated hybrid system, 
using SMPS functionalized with polyamines on the external surface, operating in an aqueous solution 
under pH and anion control.30-32 Additional systems involving carboxylates33 pseudorotaxanes,34-37 
inclusion complexes with cucurbit[6]uril38-40 cucurbit[7]uril41 and α-cyclodextrins42 have also been 
prepared. Furthermore dual pH- and photo-switched release of guests has been achieved in SMPS 
capped with boronic acid-functionalized gold nanoparticles.43 Changes in the media redox conditions 
are another popular approach to control delivery in capped mesoporous materials. Lin et al. developed 
capped materials using mesoporous scaffoldings capped with CdS, gold or magnetic nanoparticles 
attached to the SMPS through disulfide linkages that were broken up upon addition of certain reducing 
compounds.44-54 Also, the rupture of disulfide linkages in molecular based systems55 and polymeric 
networks have been used for on-command delivery.56,57 Zink and Stoddart prepared several gated 
materials triggered by redox inputs that were equipped with nanovalves based on rotaxanes and 
pseudorotaxanes containing redox active moieties.58-62   Apart from the examples described above, 
which use redox-, light- and pH-triggered systems, some additional exploratory studies that use 
alternative external stimuli such as temperature63 and the presence of certain anions64 have also been 
reported.  Another use of these hybrid gated nanomaterials deals with the development of new signaling 
protocols. The release of an entrapped dye triggered by a specific guest is used in this paradigm which 
leads to the development of novel hybrid sensing materials showing enhanced signaling features.65-67  
Although some efforts have been made to prepare SMPS containing different gate-like scaffoldings, 
the development of real systems for controlled release is still in its incipient stage. For instance, some of 
the reported systems display gating features in non-aqueous solvents, employ gate-like scaffoldings that 
require large synthetic efforts or use external stimuli that are difficult to apply to certain delivery 
applications. In addition, there is an almost complete lack of SMPS-based systems showing a selective 
delivery induced by target bio-molecules. One of the few examples involves the use of antibody-capped 
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mesoporous nanocontainers that are specifically uncapped in the presence of the corresponding 
antigen68. The enzyme-substrate system can also offer opportunities for the design of sensitive and 
specific SMPS-based nanodevices. In a first proof-of-the-concept Zink et al. functionalized the external 
surface of SMPS with a [2]rotaxane capped with an ester-linked adamantyl stopper.69,70 The 
functionalized SMPS device showed “zero release” until the addition of porcine liver esterase (PLE) 
which induced dethreading of the [2]rotaxane due to hydrolysis of the adamantyl ester. More recently, 
Bein et al. have attached avidin caps on biotinylated SMPS. 71 The avidin-biotin complex formation 
resulted in a tight closure of the pores. Addition of the protease trypsin resulted in the hydrolysis of the 
attached protein avidin and the release of the entrapped guest. The authors have contributed to the field 
reporting mesoporous silica supports capped with lactose which were selectively uncapped in the 
presence of enzyme β-D-galactosidase.72 Also, Kim et al. reported the preparation of silica nanoparticles 
functionalized through a click chemistry reaction, with β-cyclodextrin as gatekeepers.73 Addition of α-
amylase induced the release of calcein due to hydrolysis of the cyclodextrin core. 
The groundwork done suggests that enzymatic degradation of capped scaffoldings in SMPS is a 
suitable protocol for the on-command delivery of entrapped substances. In fact, the possibility of using 
enzymes for selective release applications opens a wide range of new perspectives in the development 
of bio-compatible delivery systems using silica mesoporous supports. However, as far as the authors 
know, examples of enzyme-induced delivery in living cells using capped silica mesoporous 
nanoparticles have not yet been reported.  As a continuation of the authors’ previous work in this field, 
the synthesis, characterization and controlled release experiments using nanometric SMPS 
functionalized with ‘saccharides’ are reported herein. Delivery processes in the presence of enzymes are 
studied and the internalization of ‘saccharide’-capped nanoparticles in cells is also demonstrated.  
 
RESULTS AND DISCUSSION.  
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The gated materials. The incorporation of gate-like ensembles on mesoporous scaffoldings has proved 
to be a suitable approach for the development of nanoscopic solids for mass transport and controlled 
release applications. As stated in the introduction section, most of the gated materials developed make 
use of molecular/supramolecular interactions for the fine control of cargo delivery. Very few examples 
use bio-molecules for capping or uncapping protocols. Following the authors’ interest in the application 
of biological interactions, as triggered control for delivery, attention here was centered on the use of 
enzymes as “biological-keys”. 
Scheme 1 shows the proposed paradigm for the preparation of the gated material. In this approach, 
MCM-41 was used as an inorganic scaffold in the form of nanoparticles (vide infra). The MCM-41 
support contains mesopores in the 2-3 nm range that allow the encapsulation of certain guests. The aim 
was to design bio-compatible, easy-to-prepare and low-cost capping systems in order to synthesize 
simple gated-scaffoldings to be used efficiently in delivery applications. Among different possibilities, 
attention was focused on the use of ‘saccharides’. With this goal in mind, and at the same time seeking 
to avoid complex synthetic routes to saccharide derivatives, the use of commercially-available 
hydrolyzed starch products was opted for.74 Hydrolyzed starch is obtained by the moderate hydrolysis of 
starch. The degree of starch hydrolysis is indicated by the dextrose equivalent (DE)75 which denotes the 
percentage fraction of reducing sugars in the sample (DE 1 is equivalent to non-hydrolyzed starch 
whereas DE 100 is equivalent to glucose). For this work the following dextrose equivalents (DE) were 
used; Glucidex® 47 (5% glucose, 50% maltose, 45% oligosaccharides and polysaccharides), Glucidex® 
39 (3% glucose, 37% maltose, 60% oligosaccharides and polysaccharides) and Glucidex® 29 (10% 
glucose, 9% maltose, 81% oligosaccharides and polysaccharides). Additionally, for comparative 
purposes, lactose76 was also used as a capping molecule. Carbohydrate polymers and mixtures of 
carbohydrate polymers are readily available simple saccharides that have been widely used as food 
additives and biodegradable systems and matrices for the stabilization of certain species.77   
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The hydrolyzed starch derivatives (Glucidex® 47, 39 and 29) were reacted with 3-
aminopropyltriethoxysilane in ethanol to yield the corresponding alkoxysilane derivatives (1, 2, 3) (see 
Scheme 2), whereas the capping molecule 4 was prepared via reaction of 3-aminopropyltriethoxysilane 
with lactose (see Scheme 2).78 The further anchoring of these silane derivatives 1, 2, 3 and 4 on the 
external surface of the SMPS resulted in the preparation of solids S1, S2, S3 and S4. The anchoring of 
these saccharide derivatives were expected to inhibit cargo delivery due to the formation, around the 
pore outlets, of a dense hydrogen bonding, interaction-based, ‘saccharide’ network. The working 
hypothesis predicts that in the presence of pancreatin (containing amylases able to hydrolyze the 1→4 
glycosidic bond between β-D-glucoses present in the starch) or β-D-galactosidase (able to hydrolyze 
1→4 glycosidic bond between β-D-galactose and β-D-glucose in lactose) the hydrolysis of the 
‘saccharide’ network results in an uncapping of the pores in S1-S3 and S4, respectively, allowing 
delivery of the entrapped molecule (vide infra). [Ru(bipy)3]2+ was selected as a guest for delivery. The 
delivery of the ruthenium complex from the pore voids to the aqueous solution (the uncapping protocol) 




































































































































































































































































Scheme 1. Schematic representation of the synthesis of hybrid mesoporous nanoparticles S1-S4 capped 
with trialkoxysilane carbohydrate derivatives and S5 functionalized with N-(3-
triethoxysilylpropyl)gluconamide. Addition of enzymes to S1-S4 solids would uncap the mesopores via 










































































Scheme 2. Synthesis of trialkoxysilane hydrolyzed starch derivatives 1, 2 and 3, and synthesis of 
trialkoxysilane lactose derivative 4. 
The final solids (S1, S2, S3 and S4) must ideally contain the oligosaccharide derivative anchored to 
the external surface, whereas the dye must be contained in the mesoporous channels. In order to prepare 
the final hybrid materials with these requirements a previously reported two-step synthetic procedure 
was used. In the first step, the mesoporous nanoparticles were added to a solution containing a high 
concentration of [Ru(bipy)3]2+ dye in order to achieve an efficient loading of the pores. Then, in the 
same mixture (second step of the material preparation) the hydrolyzed starch derivatized with 
trialkoxysilane moieties 1 (from Glucidex® 47), 2 (from Glucidex® 39), 3 (from Glucidex® 29) or the 
lactose derivative 4 was added to the suspensions. This would lead to hybrid materials in which the 
‘saccharides’ are basically placed on the external surface of the mesoporous support bearing in mind 
that the anchoring of the corresponding ‘saccharide’ is carried out when the mesopores are filled with 
the dye. Finally the yellow/orange solids (S1, S2, S3 and S4) were filtered, washed with water and dried 
at 40 ºC for 12 hours. As appropriate controls, solids S0, S5 and S6 were prepared. Solid S0 is an SMPS 
with [Ru(bipy)3]2+ dye filling the pores but lacking any further functionalization on the surface. Solid S5 
contains the [Ru(bipy)3]2+ dye in the pores and was additionally functionalized on the surface with the 
commercially available N-(3-triethoxysilylpropyl)gluconamide derivative (see Scheme 1). This solid, 
functionalized with a monosaccharide (a glucose derivative), assesses the degree of effect, if any, that 
the hydrolyzed starch (1, 2 and 3) and the disaccharide lactose (4) grafted on the pore outlets have on 
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the dye delivery from solids S1-S4 in the presence of suitable enzymes. Solid S6 is an SMPS without 
any dye in the interior of the pores and functionalized with the hydrolyzed starch derivative 1 (from 
Glucidex® 47). This solid was prepared exactly according to the surface functionalization procedures 
used.  
Characterization of the solids. The solids prepared were characterized using standard techniques. 
Figure 1 shows powder X-ray patterns of the solids MCM-41 as-synthesized, MCM-41 calcined and S1, 
S2, S3 and S6. The XRD of siliceous MCM-41 as-synthesized (curve a) shows the typical four low-
angle reflections of a hexagonal ordered array indexed as (100), (110), (200), and (210) Bragg peaks. 
From the XRD data an a0 cell parameter of 46.43 Å (d100 spacing of 40.21 Å) was calculated. In curve b, 
corresponding to the MCM-41 calcined sample, a significant shift of the (100) reflexion in the XRD is 
clearly observed. This displacement, together with the broadening of the (110) and (200) reflexions, is 
consistent with an approximate cell contraction of ca. 6-8 Å and attributed to the condensation of 
silanols during the calcination step. Figure 1 also shows the XRD patterns for solids S1, S2, S3 and S6 
(curves c, d, e and f, respectively). For these materials, the reflections (110) and (200) are lost, most 
likely due to a reduction of contrast as consequence of the functionalization process. Nevertheless, the 
presence of the d100 peak in the XRD patterns in all cases indicated that the process of pore loading with 
the [Ru(bipy)3]2+ complex, and the additional functionalization with the corresponding saccharides, did 
not to a large extent modify the mesoporous MCM-41 scaffolding. S4 and S5 show XRD profiles 
similar to those from S1-S3 (not shown). The presence in the final functionalized solids of the 
mesoporous structure was also confirmed from the TEM analysis, in which the typical channels of the 
MCM-41 matrix are visualized as alternate black and white stripes (see Figure 2 for MCM-41 calcined 
(a) and solid S3 (b)). The figure also shows that the prepared MCM-41-based materials are obtained as 
spherical particles with diameters ranging from 100 to 200 nm.   
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Figure 2. TEM image of MCM-41 calcined (a) and solid S3 (b) showing the typical porosity of the 
MCM-41 matrix.  
200 nm 200 nm
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The N2 adsorption-desorption isotherms of the nanoparticulated MCM-41 calcined material is shown 
in Figure 3. A typical curve for these mesoporous solids consisting of an adsorption step at intermediate 
P/P0 value (0.1-0.3) can be observed. This curve corresponds to a type IV isotherm, in which the 
observed step deals with nitrogen condensation inside the mesopores. The absence of a hysteresis loop 
in this interval and the narrow BJH pore distribution suggest the existence of uniform cylindrical 
mesopores (pore diameter of 2.29 nm and pore volume of 0.62 cm3 g-1calculated by using the BJH 
model on the adsorption branch of the isotherm). The application of the BET model resulted in a value 
of 975 m2/g for the total specific surface. From the XRD, porosimetry and TEM studies, the a0 cell 
parameter (3.98 nm), the pore diameter (2.29 nm) and a value for the wall thickness of 1.69 nm were 
calculated. In addition to this adsorption step associated to the micelle generated mesopores, a second 
feature appears in the isotherm at a high relative pressure (P/P0 > 0.8). This adsorption corresponds to 
the filling of the large voids among the particles (0.48 cm3 g-1calculated by using the BJH model) and 
therefore must be considered as a textural-like porosity. In this case, the curves show a characteristic H1 
hysteresis loop and a wide pore size distribution. 
The N2 adsorption-desorption isotherm of S1 is typical of mesoporous systems with practically filled 
mesopores (see Figure 3 c). Consequently, relatively low N2 adsorbed volume (BJH mesopore volume = 
0.13 cm3 g-1) and surface area (231 m2/g) values were calculated. In fact, this solid shows flat curves 
when compared (at the same scale) to those of the MCM-41 parent material and the S6 solid without 
dye, this indicates significant pore blocking and the subsequent absence of appreciable mesoporosity. 
Despite the significant pore volume decrease, some features can still be observed in the BJH mesopore 
size distribution such as a maximum at 1.8 nm (on the border between meso and micropores) and 
several shoulders in the 2-3 nm range. Additionally, the textural porosity is preserved and only a certain 
decrease (0.31 cm3 g-1) when compared to the parent silica is observed. S2, S3, S4 and S5 samples show 
similar N2 adsorption-desorption isotherms to that shown by S1. This is an expected result bearing in 
mind that all the solids have dye molecules sited at the pores and assuming a certain collapse of the 
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saccharide groups anchored to the pore entrances, while taking into account the dry conditions achieved 
during the sample evacuation prior to the analysis (vide infra). Similar results have been observed by the 
authors in related systems.   
An intermediate behavior between those of nanoparticulated MCM-41 and functionalized and dye 
charged samples (S1, S2, S3, S4 and S5) is observed for S6. Although the N2 adsorption-desorption 
isotherm of S6 (see Figure 3 b) is qualitatively similar to the isotherm of MCM-41 (the two well defined 
adsorption steps ascribed to the mesopores and the textural pores are preserved) an appreciable decrease 
both in the N2 volume adsorbed (BJH mesopore volume = 0.28 cm3 g-1) and surface area (567 m2/g) was 
measured as expected. The area of solid S6 was reduced ca. 40%, when compared to that presented by 
MCM-41, due to the external grafting of derivative 1. On the other hand, the difference between S1 and 
S6 isotherms is clearly related to the filled or empty (with the ruthenium dye complex) nature of the 
mesopores, respectively. Therefore, for a similar functionalization degree with sacharides, the higher 
surface area and pore volume for S6 must be due to the absence of the dye in the interior of the 
mesopores. Application of the BJH model leads to an average pore diameter of 2.16 nm. As observed 
for S1, the BJH pore size distribution shows a maximum at 1.85 nm (on the border between meso and 
micropores) and several shoulders. The presence or absence of dye inside the mesopores does not affect 
the textural-like porosity. In fact, the second adsorption step at high relative pressure (P/P0 > 0.8) which 
appears in the isotherm of S6 and similar BJH textural pore volumes can be estimated for S1 (0.31 cm3 
g-1) and S6 (0.30 cm3 g-1). This data supports the fact that the dye molecules are specifically 
incorporated inside the ordered mesopores. BET specific surface values, pore volumes, and pore sizes 
calculated from the N2 adsorption-desorption isotherms for MCM-41, S1, S2, S3, S4, S5 and S6 are 
listed in Table 1.  
Considered as a whole, the N2 adsorption-desorption data illustrate the effective pore blocking that 
occurs when the saccharide functional groups outside the pore and the dyes inside the mesopores are 
present in a cooperative way. Moreover, as previously described for related gate-like ensembles, the dry 
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conditions required for sample preparation previous to the adsorption experiments, must favor a certain 
saccharide dehydration with the subsequent collapse on the external surface. This collapse would block 
the mesopores to a large extent. In the absence of dye molecules inside the mesopores, a slightly higher 
porosity seems to be accessible for nitrogen. This last behavior is a direct consequence of the evolution 
of large complexes occupying the mesoporous voids. This loss of the cooperative blocking effect favors 
a certain increase of the internal empty volume. In all materials containing dye molecules and functional 
groups, similar pore sizes and volume values were measured. The BJH pore size distributions of these 
last materials (S1, S2, S3, S4 and S5) show maximum peaks and/or appreciable shoulders at pore sizes 
around 1.8-2.0 nm. These values (lower than those calculated for the pure silica parent material), seem 
to be more realistic than those estimated by the application of the BJH model. The decrease in mesopore 
size to the range of supermicropores could be viewed as a non-completely efficient collapse of the 
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Figure 3. Nitrogen adsorption-desorption isotherms for (a) MCM-41 mesoporous material (b) S6 and 
(c) S1 materials. Insets: Pore size distribution of each material. 
 
The contents of ‘saccharides’ and dye in solids S0, S1, S2, S3, S4, S5 and S6 were determined by 
elemental and thermogravimetric analysis and are shown in Table 2. Solids S1, S2 and S3 
functionalized on the outer surface with hydrolyzed starch showed very similar contents that range from 




Table 1. BET specific surface values, pore volumes and pore sizes calculated from the N2 adsorption-
desorption isotherms for selected materials.          




(m2 g–1) (cm3 g–1) (nm) 
MCM-41 
(nanoparticle) 
975 0.62 2.29 
S1 231 0.13 2.46 
S2 804 0.49 2.44 
S3 193 0.09 2.29 
S4 45 0.04 2.30 
S5 10 0.01 2.20 
S6 567 0.28 2.16 
aPore volumes and pore sizes are only associated with intraparticle mesopores. bPore size estimated by using the 
BJH model applied on the adsorption branch of the isotherm. 
 




(g/g SiO2) (g/g SiO2) 
S0 ____ 0.112 
S1 0.067 0.099 
S2 0.073 0.085 
S3 0.055 0.090 
S4 0.114 0.064 
S5 0.068 0.257 
S6 0.124 ____ 
 
Functional enzyme-driven controlled release. As stated above the aim was to develop enzyme-
triggered delivery systems using ‘saccharide’-capped mesoporous nanoscopic scaffolds. In this section, 
several experiments were carried out in order to study the enzyme-responsive controlled-release 
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protocol, using the capped materials, in detail. The behavior of S1, S2 and S3 in the presence of 
pancreatin and of solid S4 in the presence of β-D-galactosidase was initially analyzed in water at pH 
7.5, as these have been described as optimal conditions for enzyme-based degradation of saccharides. 
Pancreatin (a mixture of amylase, lipase and proteases) would uncap the pores through selective 
hydrolysis of the 1→4 glycosidic bond in the starch chains, whereas β-D-galactosidase, able to 
hydrolyse 1→4 glycosidic bond between β-D-galactose and β-D-glucose, would induce the pores to 
open in S4.  
In a typical experiment, S1, S2, S3 and S4 were suspended in water at pH 7.5 in the presence of and in 
the absence of the corresponding enzyme. The suspension was then stirred and the dye delivery was 
monitored through the absorption band of the [Ru(bipy)3]2+ dye at 453 nm (Figure 4 shows the delivery 
profiles). As a significant feature, the “zero release” obtained in the absence of enzyme should be noted. 
This is especially relevant when analyzing solid S3 (vide infra). In clear contrast, the solids displayed an 
enzyme-dependent cargo delivery. In more detail, solids S1, S2 and S3 released less than 2 % of the 
entrapped dye after five hours in water whereas solid S4 released 7 % of its cargo. In the presence of the 
corresponding enzyme (pancreatin for S1, S2 and S3 and β-D-galactosidase for S4) S1, S2 and S3 
delivered 63, 48 and 31 % of the cargo respectively, whereas solid S4 released 85 % of the dye (see 
Figure 4). It is clear that a simple choice of the hydrolysis degree of the starch has a dramatic influence 
in the delivery profile. Thus, at a certain time, S1 is able to deliver more cargo than S2, and S2 is able to 
deliver more cargo than S3 which is directly related to the different DE values of the hydrolyzed starch 
acting as capping scaffoldings; i.e. the lesser the hydrolysis the lower the delivery rate. Although the 
rate of hydrolysis using pancreatin (acting on S1, S2 and S3) and β-D-galactosidase (for S4) may not be 
the same, it is apparent from Figure 5 that in the presence of the corresponding enzyme the use of a 
disaccharide such as lactose as a capping system results in a higher delivery rate when compared with 
the use of hydrolyzed starch.  
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Another important feature of the prepared capped materials is the ability to release their cargo in a 
progressive fashion for prolonged periods of time. This is especially the case for S1, S2 and S3. These 
systems are able to deliver the cargo over a period of at least 60 hours (not shown), a property that could 
be of special interest to avoid unwanted drug delivery peaks. Low delivery rates have been observed 
particularly for S3 nanoparticles that release ca. 68 % of the cargo after 60 hours and would be active 
for longer periods of time. This progressive release could be related to a lowered degree of hydrolysis of 
the appended starch in S3 when compared to S1 or S2.  
In order to confirm the proposed enzyme-mediated gating mechanism solid S5 was prepared, which is 
similar to S1-S4 but contains the commercially available monosaccharide derivative N-(3-
triethoxysilylpropyl)gluconamide on the surface. This is a suitable model bearing in mind that the 
enzymatic hydrolysis of the chain capping structures in S1-S4 will ideally result in a unique glucose unit 
appended on the external surface of the solid. As can be observed in Figure 4, the ‘saccharide’-
functionalized S1-S4 showed a very low cargo release in the absence of the corresponding enzyme, 
whereas the monosaccharide-containing S5 displays a significant [Ru(bipy)3]2+ delivery under similar 
experimental conditions. These results stress the conclusion that the delivery induced in the presence of 
pancreatin or β-D-galactosidase is due to the enzymatic-mediated rupture of the glycosidic bond and 
reduction in length of the saccharide chain at the surface. To further demonstrate that both, pancreatin 
and β-D-galactosidase are responsible of the release of [Ru(bipy)3]2+ dye, additional experiments were 
carried out. First, the enzymes were denaturated by heating the solutions containing the enzymes (pH 
7.5) at 60ºC for 60 minutes before the addition of S1-S4. In a second experiment, solids S1, S2, S3 and 
S4 were incubated in the presence of the digestive protease pepsin. In both experimental settings no dye 
release was observed, strongly suggesting the selective activity of pancreatin or β-D-galactosidase 
enzymatic hydrolysis as the mechanism responsible of the opening of the mesopores.  
In order to corroborate that the gating mechanism arises from the grafting of polysaccharides in the 
pore outlets of the MCM-41 scaffold, the hybrid material S0 that contains only the [Ru(bipy)3]2+ dye in 
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the pores but lacks the hydrolyzed starch derivatives 1, 2, 3 or the disaccharide derivative 4 was 
prepared. Aqueous suspensions at pH 7.5 of solid S0 alone showed a very fast dye release, however dye 
delivery was strongly inhibited when S0 was in the presence of β-D-galactosidase or pancreatin, most 
likely due to an unselective adsorption of the enzyme on the external mesoporous surface through 
interactions with the silanol groups. This indicated that the grafting of the polysaccharides on the 
surface of mesoporous materials does not only act as capping systems that can be selectively uncapped 










Figure 4. Kinetic release of Ru(bipy)32+ dye from water suspensions of gated solids S1, S2, S3, S4 in 
the absence and in the presence of enzyme at pH 7.5, and water suspensions at pH 7.5 of solid S5, for 
five hours. 
To complete the study of the effect that the enzyme activity has on the saccharide, the solid S1-1 
(obtained from solid S1 after the uncapping process using pancreatin and delivery of the entrapped dye) 
was prepared and 13C-NMR studies were carried out. The 13C MAS NMR spectrum of samples S1 and 
S1-1 are shown in Figure 5. The 13C-NMR spectrum of S1 displays signals in the 11-50 ppm range 





















assigned to the 3-aminopropyltriethoxysilane linker, resonances between 70-90 ppm corresponding to 
the HO-C- units of the ‘saccharide’, and signals between 115-260 ppm attributed to the [Ru(bipy)3]2+ 
dye. Additionally, the characteristic 13C signal of the (-O-CH-O-) glycosidic bond is clearly found in the 
S1 solid at 100 ppm (see Figure 5). The 13C-NMR spectrum of solid S1-1 still shows some signals at the 
above mentioned shift ranges indicating the presence of certain ‘saccharide’ still anchored to the solid 
and the presence of some undelivered dye that may remain stoutly adsorbed on the walls of the 
mesopores. However, the most remarkable feature in S1-1 is the pronounced relative decrease of the 13C 
signal intensity at 100 ppm, strongly indicating that the enzymatic hydrolysis of the glycosidic bonds 
was highly effective. In fact, a certain (low) proportion of non-hydrolysed sacharides is reasonably 
expected in the S1-1 due to some steric hindrance for the complete enzymatic attack. This could be the 
origin of the complex NMR spectra in the 11-50 ppm chemical shift range associated with mixtures of 
slightly different aminopropyl arms.  
 
Figure 5. 13C MAS NMR spectrum of (a) S1 and (b) S1-1.  
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Delivery of gated materials in intracellular media. Cell internalization of mesoporous silica 
nanoparticles bearing gated stimuli-responsive scaffoldings is an appealing new interdisciplinary 
research field on the frontier of nanoscience.79-89 As stated above one goal in this study was to 
demonstrate that easy-to-prepare ‘saccharide’ capped silica mesoporous nanoparticles could be used for 
in cell delivery applications. Thus, after the in vitro characterization of the different ‘saccharide’-capped 
mesoporous scaffolds (vide ante), S1 nanoparticles were selected for further ex vivo assays. Previous 
reports suggested that saccharides can be used as targeting molecules in modified nanoparticles in order 
to induce efficient uptake by target cells via endocytosis.90,91 Therefore, saccharide-capped SMPS could 
be good candidates for the design of intracellular cargo-releasing specialized nanodevices.  
Initially, an evaluation of the ability of cells to internalize S1 and the suitability of the nanoparticles in 
terms of cellular toxicity was performed (Figure 6). Confocal microscopy analysis was used in order to 
evaluate whether or not S1 was internalized in both the tumoral HeLa and non-tumoral LLC-PK1 cell 
lines (see Materials and Methods section for further information) tracking the [Ru(bipy)3]+2 
fluorescence. In these experiments cell nuclei were stained with Hoechst 33342 and cellular membrane 
with the fluorescent marker WGA Alexa Fluor® 647 as cellular markers. A dotted pattern of a 
[Ru(bipy)3]+2 fluorescent signal associated to intracellular vesicles was observed (Figures 6a and 6b for 
HeLa and LLC-PK1 cells, respectively) suggesting S1 internalization in both cell lines. A WST-1 cell 
viability assay was employed to determine any unspecific toxicity of S1. The output of the assay 
suggested that S1 was well tolerated by the cells in the experimental conditions (Figure 6c).   
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Figure 6. Cellular uptake of S1. a) HeLa and b) LLC-PK1 cells were incubated for 20 minutes in the 
presence of S1 50 μg/mL. Next, the medium was removed and fresh medium was added. After 15 hours, 
confocal microcopy studies of S1 cellular uptake were performed by means of [Ru(bipy)3]+2-S1 
associated fluorescence (red) in the presence of DNA marker Hoechst 33342 (blue) and the plasma 
membrane marker WGA Alexa Fluor® 647 (green).  For cell viability studies, (c) HeLa and LLC-PK1 
cells were treated with S1 in the same conditions at concentrations of 50, 25, 10 and 5 μg/mL (black, 
grey, stripped and white bars, respectively) for 24 h. Then, cell viability was quantified by means of a 
WST-1 assay. Three independent experiments were performed and data are reported as (mean ± s). 
 
The presence of S1-containing intracellular vesicles suggested an endosomal (or endosomic)-mediated 
cellular internalization. Such a mechanism is generally used in cellular systems to transport different 
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substrates to the autolysosomes for bulk degradation in an energy-dependent process.92-94 Therefore it is 
conceivable to postulate that cargo-containing S1 is transported to the autolysosomes where the activity 
of lysosome enzymes (including amylases) induces a saccharide hydrolysis-dependent release of the 
entrapped guest. To characterize the way S1 nanoparticles are internalized, HeLa and LLC-PK1 cells 
were incubated in the presence of S1 at 37 ºC and 4 ºC and the [Ru(bipy)3]+2 associated fluorescence 
was measured (Figure 7a and 7b). A statistically significant reduction of S1 cellular uptake in both cell 
lines was observed upon incubating cells at 4 ºC when compared to the uptake obtained at 37 ºC. This 
fact would indicate an energy dependent internalization mechanism. Additionally, and interestingly, an 
increased uptake at all temperatures analyzed for tumoral HeLa cells when compared to non-tumoral 
LLC-PK1 cells was observed. To further characterize the internalization process, HeLa cells were 
transfected with the autolysosome marker microtubule-associated protein 1 light chain 3 (LC3-I) 
fusionated to the green fluorescent protein (GFP, LC3-eGFP).95 The LC3-I protein presents a 
cytoplasmic localization under normal conditions. In the presence of inductors of autolysosome 
formation, it is processed and recruited to the autolysosomes, where LC3 II is generated by site specific 
proteolysis and lipidation near to the C-terminus. This fact induces the appearance of a dotted pattern 
related to the membrane associated LC3-II new subcellular localization. Once transfected, cells were 
treated with S1 and the fluorescence associated to the [Ru(bipy)3]+2 dye was determined. As a result, a 
certain number of cells showed a dotted [Ru(bipy)3]+2 pattern surrounded by LC3-eGFP-associated 
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Figure 7.  Implication of endosomes and lysosomes in the cellular degradation of S1. HeLa and LLC-
PK1 cells were treated S1 50 and 25 μg/mL at 37 ºC and 4 ºC. After 20 minutes, nanoparticles were 
removed and cells were further incubated at 37 ºC for 24 h. Then, [Ru(bipy)3]+2 associated fluorescence 
was studied by means of flow cytometry. In figure b, columns indicate the percentage of cells which 
stained positive for [Ru(bipy) 3]+2 in HeLa and LLC-PK1 cells at 37 ºC (black bars) and 4ºC (white 
bars), respectively. Three independent experiments were performed employing duplicates. Results are 
expressed as (mean ± s). Statistically significant data (Student’s t test, P < 0.05) were obtained in all 
cases when comparing the two different incubation temperatures.  To determine the autolysosomal 
localization of S1 nanoparticles, HeLa cells were transfected with LC3-eGFP and 24 h later treated with 
S1 50 and 25 μg/mL for 20 minutes. After the treatment, the medium was changed and further incubated 
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for 24 h prior to determination through confocal microscopy of the localization of [Ru(bipy)3]+2 
associated fluorescence (red) and LC3-eGFP (green). As a result, autolysosomal localization of S1 was 
determined (white arrow). 
In order to prove the lysosomal amylase-mediated degradation of the capping “saccharides” of S1, 
new capped mesoporous nanoparticles were synthesized and loaded with the chemotherapeutic agent 
doxorubicin (dox) as a guest molecule (S1-DOX).96 S1-DOX shows a similar N2 adsorption-desorption 
isotherm, XRD profile and TEM images to that observed for S1 (data not shown). The content of dox in 
solid S1-DOX was determined by elemental and thermogravimetric analysis and amounted to 0.278 g of 
dox/ g SiO2. Kinetic release of dox from water suspensions of the gated S1-DOX solid in the presence 
and absence of enzyme at pH 7.5 were carried out, and a similar delivery behavior to that found for S1 
was observed; i.e. zero delivery in the absence of amylases and delivery in the presence of the enzymes. 
Based on these observations in vitro, further ex vivo assays were carried out.  Dox is broadly employed 
in the treatment of cancer. However, the non-specific cell internalization of this drug causes significant 
secondary effects in treated patients (i.e. cardiotoxic and nephrotoxic effects). Confining dox in 
nanoparticles for more-specific cellular release has been reported to be an interesting strategy to 
decrease the unwanted secondary effects, thereby increasing the efficiency of this drug.97 S1-DOX 
nanoparticles were added to the cells at different concentrations and cellular localization and cell 
toxicity was examined by confocal microscopy and flow cytometry after 24 h (Figure 8). As 
experimental controls, MCM-41 material and the supernatant of the S1-DOX suspension employed to 
treat the cells were also added in the same conditions as S1-DOX. MCM-41 was used in order to 
discard any toxic effect associated with the mesoporous material, while a S1-DOX suspension was 
employed to discard any unspecific aperture of the molecular gate outside the cells. A significant 
percentage of S1-DOX treated cells detached from the plate, due to the activation of dox-induced cell 
death, were observed by confocal microscopy studies. By contrast, no cell death was observed in MCM-
41-treated cells (Figures 8 a-d) or in the case of the supernatant of the S1-DOX suspension (data not 
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shown). These results strongly suggest that dox delivery is only observed upon S1-DOX internalization 
and enzyme-mediated aperture of the “saccharide” gate. The quantification of the percentage of cell 
death was performed by flow cytometry (measured by DNA content staining with DAPI). Cellular 
population in normal conditions typically distributes in a two peak graphic depending on their DNA 
content; i.e. cells in G1- or G2-phase, whereas a cell undergoing cell death usually presents a sub-G1 
DNA content due to cellular fragmentation and subsequent DNA loss. A typical cell cycle distribution 
was observed in cells treated with MCM41 (Figure 8 e). In the case of cells treated with S1-DOX, the 
typical cell cycle distribution was lost and a significant percentage of cells presented a sub-G1 DNA 
content corresponding to dead cells (Figure 8 e-f). These results indicate that nanoscopic SMPS 
functionalized with ‘saccharide’ derivatives are suitable supports for the delivery of entrapped 
molecules into cells for biological applications. 
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Figure 8. S1-DOX cell internalization induces cell death. HeLa cells were treated with control MCM-
41 (a, b) or S1-DOX (c, d) at 50, 25 µg/mL and after 20 minutes, the medium was removed and cells 
were further incubated for 24 h. MCM-41-treated cells remained attached to the plate (a) and showed 
standard phenotype in confocal microscopy analysis (b) when nuclei were stained with Hoechst 33342 
(blue) and plasma membrane with WGA Alexa Fluor® 647 (green).  In contrast, S1-DOX-treated cells 
were detached from the plate (c) and an ‘in cell’ diffuse pattern of dox-associated fluorescence (red) 
together with cellular corpses were observed (d) suggesting dox-induced cell death.  Quantification of 
cell death was performed by flow citometry. DNA content was studied by fixing the cells in ethanol and 
staining them with DAPI. MCM-41 treated cells presented a standard cell cycle distribution, while a 
significant percentage of S1-DOX treated cells presented a sub-G1 DNA content proving the existence 
of cell death processes (Figure 8e). A quantification of the percentage of cells in sub-G1 phase is shown 
in Figure 8f. Two independent experiments were performed employing duplicates in both cases. Results 




In conclusion, it has been demonstrated that the attachment of a hydrolyzed starch derivative as a 
gatekeeper on the surface of MSNs supports provides a suitable method for the design of mesoporous 
systems able to deliver the entrapped guest in the presence of suitable enzymes. Specifically, the 
mesoporous silica nanoparticles S1, S2 and S3 containing different grafted starch derivatives (i.e. 
Glucidex® 47, Gludicex® 39 and Glucidex® 29) showing a different degree of hydrolysis were prepared. 
Additionally, for comparative purposes, solid S4 containing a lactose derivative as a capping molecule 
was also prepared. Whereas the capped S1-S4 solids showed “zero release”, the same solids in water in 
the presence of pancreatin (for S1-S3) and galactosidase (for S4) released the cargo in a controlled 
fashion due to the enzyme-induced hydrolysis of the glycosidic bonds in the anchored ‘saccharides’. A 
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clear control of the delivery rate was additionally found depending on the used hydrolyzed starch 
derivative. The delivery results indicate that it is possible to design different delivery profiles via a 
simple selection of the degree of hydrolyzation of the starch (i.e. related to the lengths of different 
‘saccharide’ components and their relative proportions). It was shown that the ‘saccharide’-
functionalized nanoparticles S1 are efficiently taken up by both tumoral (HeLa) and non-tumoral (LLC-
PK1) cells although a more efficient internalization in HeLa cells was observed. The cellular uptake of 
the nanoparticles occurs via endocytosis targeting them to the autolysosomes, where the capping 
polysaccharides are degraded by lysosomal enzymes and the cargo is delivered. Finally, the possible 
application of ‘saccharide’-functionalized nanoparticles as suitable delivery systems in cells of 
chemotherapeutic agents such as doxorubicin was demonstrated, and a substantial reduction of cell 
viability was observed in cells treated with solid S1-DOX. These results suggest that it might be 
possible to use bio-scaffoldings (for instance ‘saccharide’ as demonstrated here) as capping systems for 
the preparation of biocompatible delivery nanodevices based on silica mesoporous supports. The 
possibility of using these “bio-gates” which could be selectively opened by bio-molecules (for instance 
enzymes) opens a wide range of possibilities in the design of advanced nanodevices for controlled 
delivery applications and a number of new advances in this area are anticipated.  
 
EXPERIMENTAL. 
Synthesis. General methods. XRD, TGA, elemental analysis, TEM, N2 adsorption-desorption, NMR 
and UV-visible spectroscopy techniques were employed to characterize the synthesized materials. 
Powder X-ray measurements were performed on a Philips D8 Advance diffractometer using Cu Kα 
radiation. Thermo-gravimetric analyses were carried out on a TGA/SDTA 851e Mettler Toledo balance, 
using an oxidant atmosphere (air, 80 mL/min) with a heating program consisting of a heating ramp of 10 
ºC per minute from 393 to 1273 K and an isothermal heating step at this temperature for 30 minutes. 
TEM images were obtained with a 100 kV Philips CM10 microscope. N2 adsorption-desorption 
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isotherms were recorded with a Micromeritics ASAP2010 automated sorption analyzer. The samples 
were degassed at 120 ºC in vacuum overnight. The specific surface areas were calculated from the 
adsorption data in the low pressure range using the BET model. Pore size was determined following the 
BJH method. 1H and 13C nuclear magnetic resonance (NMR) spectra were acquired with a Varian 300 
spectrometer (Sunnyvale, CA, USA). 13C MAS NMR spectrum was recorded on a Varian Unity 300 
spectrometer operating at 128.3 MHz using a magic angle spinning speed of 4.0 kHz. UV-visible 
spectroscopy was carried out with a Lambda 35 UV/vis spectrometer (Perkin-Elmer Instruments). Live 
cellular internalization studies were performed with a Cytomics FC 500 (Beckman Coulter Inc.) and a 
confocal Leica microscope handled with a TCS SP2 system, equipped with an acoustic optical beam 
splitter (AOBS). Cell viability measurements were carried out with a Wallac 1420 workstation.  
Chemicals. The chemicals tetraethylorthosilicate (TEOS), n-cetyltrimethylammonium bromide 
(CTABr), sodium hydroxide (NaOH), 3-aminopropyltriethoxysilane, tris (2, 2’bipyridyl) ruthenium (II) 
chloride hexahydrate([Ru(bipy)3]Cl2·6H2O), Pancreatin from porcine pancreas, β-D-galactosidase from 
Kluyveromyces lactis, D-(+)-Lactose monohydrate and tissue culture grade dimethylsulfoxide (DMSO) 
were provided by Aldrich. N-(3-triethoxysilylpropyl) gluconamide was provided by ABCR. The 
hydrolyzed starch Glucidex® 47 (5% glucose, 50% maltose, 45% oligosaccharides and polysaccharides), 
Glucidex® 39 (3% glucose, 37% maltose, 60% oligosaccharides and polysaccharides) and Glucidex® 29 
(10% glucose, 9% maltose, 81% oligosaccharides and polysaccharides) were provided by Roquette. D-
MEM with L-glutamine, fetal calf serum (FCS), trypan blue solution (0.4 %) cell culture grade, trypsin, 
wheat germ agglutinin Alexa Fluor® 647 and Hoechst 33342 were provided by Gibco-Invitrogen. The 
cell proliferation reagent WST-1 was obtained from Roche Applied Science. Doxorubicin hydrochloride 
was provided by Sequoia Research Products Ltd. All the products were used as received. 
Synthesis of the hydrolyzed starch derivative 1, 2, 3 (Scheme 2). A solution of 3-
aminopropyltriethoxysilane (5.85 mL, 25 mmol) in ethanol was added to a suspension of hydrolyzed 
starch (Glucidex® 47, Glucidex® 39  and Glucidex® 29) in ethanol (total volume 250 mL). The reaction 
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mixture was stirred for 24 h at room temperature and then heated at 60ºC for 30 min. The solvent was 
evaporated under reduced pressure to give a white solid (1, 7.32 g, yield 84 %; 2, 7.15 g, yield 82 %; 3, 
7.55 g, yield 87 %. 1H NMR (300 MHz, D2O): δ 0.42 (t, 2 H, -CH2-Si-), 1.02 (t, 9 H, CH3-CH2-O-Si-), 
1.53 (m, 2 H, -CH2-CH2-Si-), 2.74 (t, 2 H, -NH-CH2-CH2-CH2-Si-), 3.20-3.77 (m, n H, starch 
hydrolyzed, CH3-CH2-O-Si-), 5.13 (d, 1 H, -O-CH-O-) ppm. 13C{1H } NMR (75MHz, D2O): δ  9.62 (-
CH2-Si-), 16.65 (CH3-CH2-O-Si-), 21.74 (-CH2-CH2-Si-), 41.96 (-NH-CH2-CH2-CH2-Si-), 57.25 (CH3-
CH2-O-Si-), 61.84 (HO-CH2-CH-), 72.67-78.11 (HO-CH-), 89.57 (-O-CH-CH),  94.84 (-O-CH-NH-), 
100.25 (-O-CH-O-) ppm. 
Synthesis of the lactose derivative 4 (Scheme 2). A solution of 3-aminopropyltriethoxysilane (5.85 
mL, 25 mmol) in ethanol was added to a suspension of lactose monohydrate (5.4 g, 15 mmol), in 
ethanol (total volume 250 mL). The reaction mixture was stirred for 24 h at room temperature and then 
heated at 60ºC for 30 min. The solvent was evaporated under reduced pressure to give a white solid (4, 
7.22 g, 13.24 mmol, yield 89 %). 1H NMR (300 MHz, D2O): δ 0.46 (t, 2 H, -CH2-Si-), 1.03 (t, 9 H, 
CH3-CH2-O-Si-), 1.56 (m, 2 H, -CH2-CH2-Si-), 2.77 (t, 2 H, -NH-CH2-CH2-CH2-Si-), 3.34-3.93 (m, 19 
H, Lactose, CH3-CH2-O-Si-), 4.29 (d, 1 H, -O-CH-O-) ppm. 13C{1H } NMR (75MHz, D2O): δ  10.89 (-
CH2-Si-), 17.52 (CH3-CH2-O-Si-), 23.32 (-CH2-CH2-Si-), 43.18 (-NH-CH2-CH2-CH2-Si-), 58.17 (CH3-
CH2-O-Si-), 61.77 (HO-CH2-CH-), 69.31 (HO-CH-),71.72 (HO-CH-), 73.27 (HO-CH-), 76.11 (-O-CH-
CH), 79.19 (-O-CH-NH-), 103.68 (-O-CH-O-) ppm. Mass spectra (M = C21H43NO13Si): 545 (M+1), 
461(M−(CH3-CH2-)3), 369 (M−(CH3-CH2-O-)3-Si-CH2-), 326 (M−(CH3-CH2-O-) 3-Si-CH2-CH2-CH2-
NH-), 221(M−Lactose), 135 (M−Lactose-NH-CH2-CH2-CH2-Si-). 
Synthesis of mesoporous MCM-41 nanoparticles. The MCM-41 mesoporous nanoparticles were 
synthesized using the following procedure: n-cetyltrimethylammoniumbromide (CTABr, 2.00 g, 5.48 
mmol) was first dissolved in 960 mL of deionized water. NaOH (aq) (2.00 M, 7.00 mL) was added to 
the CTABr solution, followed by adjusting the solution temperature to 95ºC. TEOS (10.00 mL, 5.14.10-
2 mol) was then added dropwise to the surfactant solution. The mixture was allowed to stir for 3 h to 
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give a white precipitate. The solid product was centrifuged, and washed with deionized water and 
ethanol. Finally the solid was dried at 60ºC (MCM-41 as-synthesized). To prepare the final porous 
material (MCM-41), the as-synthesized solid was calcined at 550 ºC using an oxidant atmosphere for 5 
h in order to remove the template phase. 
Synthesis of S1, S2, S3. (Scheme 1). In a typical synthesis, 1.00 g of templated-free MCM-41 and the 
dye tris(2,2’-bipyridyl) ruthenium (II) chloride (0.6 g, 0.8 mmol) were suspended in 40 mL of water in a 
round-bottomed flask under inert atmosphere. The mixture was stirred for 24 h at room temperature 
with the aim of achieving the maximum loading in the pores of the MCM-41 scaffolding. Then, an 
excess of the corresponding alkoxysilane derivative 1, 2 and 3 (1g) in 20 mL of water, was added and 
the final mixture was stirred for 5.5 h at room temperature. Finally, the solid (S1, S2, S3) was filtered 
off, washed with 40 mL of water, and dried at 40ºC for 12 hours. 
Synthesis of S1-DOX. In a typical synthesis, 1.00 g of templated-free MCM-41 and doxorubicin 
hydrochloride (0.5 g, 0.91 mmol) were suspended in 40 mL of water in a round-bottomed flask under 
inert atmosphere. The mixture was stirred for 24 h at room temperature with the aim of achieving the 
maximum loading in the pores of the MCM-41 scaffolding. Then, an excess of the alkoxysilane 
derivative 1 (1g) in 20 mL of water was added, and the final mixture was stirred for 5.5 h at room 
temperature. Finally, the solid (S1-DOX) was filtered off, washed with 40 mL of water, and dried at 
40ºC for 12 hours. 
 Synthesis of S4. (Scheme 1). In a typical synthesis, 1.00 g of templated-free MCM-41 and the dye 
tris(2,2’-bipyridyl) ruthenium (II) chloride (0.6 g, 0.8 mmol) were suspended in 40 mL of water in a 
round-bottomed flask under inert atmosphere. The mixture was stirred for 24 h at room temperature 
with the aim of achieving the maximum loading in the pores of the MCM-41 scaffolding. Then, an 
excess of the alkoxysilane derivative 4 (1g, 1.8 mmol) in 20 mL of water was added, and the final 
mixture was stirred for 5.5 h at room temperature. Finally, the solid (S4) was filtered off, washed with 
40 mL of water, and dried at 40ºC for 12 hours. 
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Synthesis of S5. (Scheme 1). 1.0 g of templated-free MCM-41 and the dye tris(2,2’-
bipyridyl)ruthenium(II) chloride (0.6 g, 0.8 mmol) were suspended in 40 ml of anhydrous acetonitrile 
and heated at 120º C in a Dean-Stark in order to remove the adsorbed water by azeotropic distillation 
under inert atmosphere. The suspension was stirred for 24 hours at room temperature with the aim of 
loading the pores of the MCM-41 scaffolding. After this, an excess of the commercially available N-(3-
triethoxysilylpropyl)gluconamide (50% in ethanol, 1.05 mL, 1.31 mmol) was added and the suspension 
was stirred for 5.5 hours. The final orange solid (S5) was filtered, washed with acetonitrile and dried at 
40 ºC for 12 hours. 
Synthesis of  S6.  In a typical synthesis, 1.00 g of templated-free MCM-41 was suspended in 40 mL of 
water in a round-bottomed flask under inert atmosphere, an excess of the alkoxysilane derivative 1 (1g)  
was added, and the mixture was stirred for 5.5 h at room temperature. Finally, the solid S6 was filtered 
off, washed with 40 mL of water, and dried at 40ºC for 12 hours. 
Synthesis of S0. For the sake of comparison, and as a control solid, hybrid material containing only 
the [Ru(bipy)3]2+ dye (S0) was synthesized in order to assess the effect of the saccharide grafted in the 
outer of the MCM-41 pores. The procedure was the same as described for S1, S2, S3 and S4 but without 
grafting the saccharide derivative. The final orange solid (S0) was filtered, washed with water and dried 
at 40 ºC for 12 hours. 
 Dye release studies. In a typical experiment, 10 mg of S1, S2, S3 and S4 were suspended in 18.75 
mL of water at pH 7.5 and then 6.25 mL of enzyme solution (0.4 g of enzyme in 100 mL of water at pH 
7.5) was added. Pancreatin was used for solids S1, S2, S3 and β-D-galactosidase for solid S4. The 
suspensions were used for the evaluation of the gate-like effect by studying dye release from the pore 
voids of the functionalized material via the rupture of a glycosidic bond. For release studies with S0 and 
S5 10 mg of the solid were placed in 25 mL of water at pH 7.5 and at a certain time an aliquot was 
separated and filtered. The delivery of the dye from the pore voids to the aqueous solution was 
monitorized via the absorbance of the dye at 453 nm. 
 33 
Cell culture conditions. The HeLa human cervix adenocarcinoma and the LLC-PK1 pig kidney cells 
were purchased from the German Resource Centre for Biological Materials (DSMZ) and were grown in 
D-MEM and Medium 199 supplemented with 10 % and 6% FCS, respectively. Cells were maintained at 
37 ºC in an atmosphere of 5 % carbon dioxide and 95 % air and underwent passage twice a week. Cells 
were transfected with eGFP-C1 plasmid containing the rat LC3 gene (LC3-eGFP) (kindly provided by 
G. Kroemer) by means of lipofectamine transfection reagent (Invitrogen), according to the 
manufacturer’s recommendations. 
WST-1 cell viability assay. Cells were cultured in sterile 96-well microtiter plates at a seeding density 
of 2.5·103 and 8·103 cells/well for HeLa and LLC-PK1 , respectively, and they were allowed to settle 
for 24 h. S1 in DMSO was added to cells at a final concentration of 50, 25, 10 and 5 µg/mL. After 23 h, 
WST-198 (10 µL of a 5 mg/mL solution) was added to each well. Cells were further incubated for 1 h (a 
total of 24 h of incubation was therefore studied) and absorbance was measured at 595 nm.  
Live confocal microscopy S1 cellular internalization. HeLa and LLC-PK1 cells were seeded in 24 
mm Φ glass cover-slips in six-well plates at a seeding density of 105 cells / well. 24 h later, cells were 
treated when indicated with S1 or S1-DOX at a final concentration of 50 µg/ml. 20 minutes later, the 
medium was removed to eliminate compounds. After 15 h of incubation, cells were stained with 10 
ng/mL of Hoechst 33342 and 5 mg/mL wheat germ agglutinin (WGA) Alexa Fluor® 647 for 30 min in 
PBS containing 10 % FCS or keeping the medium in case of S1-DOX treatments. Slides were 
visualized under a confocal microscope. 
Cytofluorometry studies employing S1. To develop the cytofluorometry studies, HeLa and LLC-PK1 
cells were seeded at 50x103 cells/well in a twelve-well plate. After 24 h, cells were treated with S1-
DOX 50 µg/mL for 20 minutes before removing the culture medium. Cells were incubated for 15 h 
before fixing them with ethanol 80%, keeping them at – 20 ºC for 24 h. Finally, cells were stained with 
DAPI CONCENTRATION and cell cycle studies were performed to determine the cell viability of the 
samples.  
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